Ketanserin: A novel cardiovascular drug

✍ Scribed by Jan Symoens; Monique Janssens

• Book ID: 102817477
• Publisher: John Wiley and Sons
• Year: 1986
• Tongue: English
• Weight: 829 KB
• Volume: 8
• Category: Article
• ISSN: 0272-4391
• DOI: 10.1002/ddr.430080119

✦ Synopsis

Extensive clinical investigation has shown that ketanserin is an effective first-line antihypertensive agent with particular advantages in older patients. It has a favorable hemodynamic profile and seems devoid of serious side-effects. Clinical studies in various diseases indicate a gradual improvement of the microcirculation, which is compatible with selective serotonin S2-antagonism. Ketanserin has a favorable influence on several cardiovascular risk factors. Preliminary data suggest that it has vascular protective effects in patients with atherosclerosis.